Mark Nelson, MD

Trials

Studies that name Mark Nelson, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:46 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT04707625 · Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

  Wake Forest University Health Sciences · terminated · Retinal Vein Occlusion · principal investigator
• Ph4
  NCT04075136 · Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

  Wake Forest University Health Sciences · withdrawn · Exudative Age Related Macular Degeneration · principal investigator
• N/A
  NCT03340116 · Measurement of Blood Volume Loss During Burn Surgery

  Virginia Commonwealth University · withdrawn · Surgical Blood Loss, Burns · principal investigator
• Ph4
  NCT02285374 · Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity

  St Stephens Aids Trust · unknown · HIV · principal investigator
• N/A
  NCT00660608 · Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery

  Virginia Commonwealth University · completed · Coronary Artery Disease · principal investigator
• Ph1
  NCT00373633 · Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain

  Virginia Commonwealth University · terminated · THoracotomy · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.